Cadila Healthcare has reported results for first quarter ended June 30, 2019.
The company has reported a fall of 74.63% in its net profit at Rs 78.70 crore for the quarter under review as compared to Rs 310.20 crore for the same quarter in the previous year. Total income of the company decreased by 14.91% at Rs 1,370.80 crore for Q1FY20 as compared Rs 1,611.00 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 34.07% in its net profit at Rs 303.60 crore for the quarter under review as compared to Rs 460.50 crore for the same quarter in the previous year. However, total income of the company increased by 17.49% at Rs 3,518.90 crore for Q1FY20 as compared Rs 2,995.00 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1525.00 |
Dr. Reddys Lab | 5942.65 |
Cipla | 1345.35 |
Zydus Lifesciences | 925.95 |
Lupin | 1547.05 |
View more.. |